Latest Whitepapers

Droplet Digital PCR (ddPCR) is a refined form of digital PCR that offers a scalable and practical method for the absolute quantification of nucleic acids. 2021 marks ten years since the advent of ddPCR and in that time it has revolutionized discovery, development and quality control of biopharmaceuticals such as antibody-based biologics, vaccines, and cell and gene therapies.

Validation is an important process to ensure cleanrooms meet specific standards to be classified according to the International Standards Organization (ISO). ISO classifications ensure the integrity of the products, ranging from pharmaceuticals to semiconductors, contained in the cleanroom.

Download this whitepaper to uncover predicting disease onset via clinical biomarkers as well as other potential applications in diabetes research.

This whitepaper, including 15 peer-reviewed publications across various RNA applications, demonstrates how researchers used automated electrophoresis for sample quality control and fragment analysis to ensure high-quality RNA and cDNA samples.

The battle against COVID-19 only begins with a test to identify who is infected and who is not. To accelerate an effective response, we have to move beyond the initial diagnosis to prognosis: Who is most susceptible to developing serious, life-threatening symptoms?

Supply chain security and transparency is a key part of the risk mitigation strategy of companies manufacturing clinical diagnostic assays. Prior to the COVID-19 crisis, complex global supply chains carefully balanced capacity with demand while cost-cutting initiatives pushed towards lower cost raw material providers located in different geographies.

Over the last decade, the number of clinical trials involving recombinant adeno-associated viral (AAV) vectors has dramatically increased, the diversity of serotypes has expanded and the demand for larger quantities of highly purified material manufactured to cGMP standards has rocketed.

Download this whitepaper to discover how a contract development manufacturing organization was able to establish an AAV production platform and much more.

The efficiency of candidate antibody discovery pipelines is directly connected to the quality of the DNA library being screened. To reduce discovery timelines, researchers need access to tools allowing them to take more shots on goal, as well as line up these shots effectively.

Immunotherapy has the potential to treat a wide variety of conditions, from autoimmune disease to cancer. However, the discovery of potential antibody therapeutics against key receptor proteins remains a major challenge for the traditional immunisation approaches currently available on the market.